ask="44.50"
ask_size="100"
average_daily_volume="1117400"
bid="38.64"
bid_size="1000"
book_value="4.05"
change="-0.23"
change_from_200_day_moving_average="-6.72"
change_from_50_day_moving_average="-0.97"
change_from_52_week_high="-15.02"
change_From_52_week_low="8.88"
change_in_percent="-0.57%"
close="40.13"
dividend_pay_date="N/A"
dividend_per_share="0.00"
dividend_yield="0.00"
earnings_per_share="-1.45"
ebitda="-134.59M"
eps_estimate_current_year="-1.63"
eps_estimate_next_quarter="-0.48"
eps_estimate_next_year="-1.84"
ex_dividend_date="N/A"
float_shares="85794000"
high="40.28"
high_52_weeks="55.15"
last_trade_date="1/30/2017"
last_trade_price="40.13"
last_trade_size="154958"
last_trade_time="4:00pm"
low="38.98"
low_52_weeks="31.25"
market_capitalization="3.49B"
moving_average_200_day="46.85"
moving_average_50_day="41.10"
name="Neurocrine Biosciences
Inc."
notes="N/A"
one_year_target_price="66.92"
open="40.13"
pe_ratio="N/A"
peg_ratio="0.68"
percent_change_from_200_day_moving_average="-14.34%"
percent_change_from_50_day_moving_average="-2.35%"
percent_change_from_52_week_high="-27.23%"
percent_change_from_52_week_low="+28.42%"
previous_close="40.36"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="9.97"
price_per_sales="233.74"
revenue="15.00M"
shares_outstanding="86871000"
short_ratio="3.55"
stock_exchange="NMS"
symbol="NBIX"
volume="850322"
weeks_range_52="31.25 - 55.15"
